shortagewatch

Home / Cancer and immune system / Bendamustine

ATC L01AA09 · Antineoplastic Agents

Bendamustine shortage

As of 31 Oct 2026, Bendamustine has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Belgium), covering 15 products.

Countries4/5
Products15packs or presentations
Short since1 May 20224.5 years ago
Earliest return3 Nov 2026company estimate
No return date7products
Main reasonNot stated
Germany1 pack shortItaly3 packs shortSpain10 packs shortAustriaNo reported shortageBelgium1 pack short

Timeline

GermanyItalySpainBelgium
2023202420252026Bendamustin beta 180 mg/4 ml Konzentrat zur Bendamustin beta 180 mg/4 ml Konzentrat zur Herstellung einer InfusionslösungBENDAMUSTINA MEDACBENDAMUSTINA MEDACBENDAMUSTINA MEDACBENDAMUSTINA MEDACBENDAMUSTINA AUROBINDOBENDAMUSTINA AUROBINDOBENDAMUSTINA DR. REDDYS 2,5 MG/ML POLVO PARABENDAMUSTINA DR. REDDYS 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mgBENDAMUSTINA DR. REDDYS 2,5 MG/ML POLVO PARABENDAMUSTINA DR. REDDYS 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 25 mgBENDAMUSTINA BAXTER 2,5 MG/ML POLVO PARA CONBENDAMUSTINA BAXTER 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG 5 viales de 100 mgBENDAMUSTINA AUROVITAS 2.5 MG/ML POLVO PARA BENDAMUSTINA AUROVITAS 2.5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mgBENDAMUSTINA ACCORD 2,5 MG/ML POLVO PARA CONBENDAMUSTINA ACCORD 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 5 viales de 100 mgBENDAMUSTINA ACCORD 25 MG/ML CONCENTRADO PARBENDAMUSTINA ACCORD 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION , 5 viales de 4 mlBENDAMUSTINA GLENMARK 2,5 MG/ML POLVO PARA CBENDAMUSTINA GLENMARK 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mgBENDAMUSTINA KABI 2,5 MG/ML POLVO PARA CONCEBENDAMUSTINA KABI 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mgBENDAMUSTINA HIKMA 2,5 MG/ML POLVO PARA CONCBENDAMUSTINA HIKMA 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mgBENDAMUSTINA HIKMA 2,5 MG/ML POLVO PARA CONCBENDAMUSTINA HIKMA 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 25 mgBendamustine Accord 25 mg/ml inf. sol. (concBendamustine Accord 25 mg/ml inf. sol. (conc.) i.v. vial 5 x 4 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEBendamustin beta 180 mg/4 ml Konzentrat zur Herstellung einer Infusionslösungbetapharm Arzneimittel GmbH1 May 202231 Dec 2026Manufacturing problem
Produktionsproblem
ITBENDAMUSTINA MEDACMEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH20 Feb 2026not givenIncreased demand
Elevata richiesta
ITBENDAMUSTINA MEDACMEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH2 Mar 2026not givenIncreased demand
Elevata richiesta
ITBENDAMUSTINA AUROBINDOEugia Pharma (Malta) Limited21 Mar 2026not givenManufacturing problem
Problemi produttivi
ESBENDAMUSTINA DR. REDDYS 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mgReddy Pharma Iberia S.A.11 May 2025not givenNot stated
ESBENDAMUSTINA DR. REDDYS 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 25 mgReddy Pharma Iberia S.A.3 Jun 2025not givenNot stated
ESBENDAMUSTINA BAXTER 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG 5 viales de 100 mgBaxter S.L.18 Jun 2025not givenNot stated
ESBENDAMUSTINA AUROVITAS 2.5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mgEugia Pharma (Malta) Limited21 Oct 202529 Nov 2026Not stated
ESBENDAMUSTINA ACCORD 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 5 viales de 100 mgAccord Healthcare S.L.U.26 Feb 202630 Dec 2026Not stated
ESBENDAMUSTINA ACCORD 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION , 5 viales de 4 mlAccord Healthcare S.L.U.19 May 202630 Dec 2026Not stated
ESBENDAMUSTINA GLENMARK 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mgGlenmark Arzneimittel Gmbh15 Sep 202629 Nov 2026Not stated
ESBENDAMUSTINA KABI 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mgFresenius Kabi España, S.A.U.6 Oct 20263 Nov 2026Not stated
ESBENDAMUSTINA HIKMA 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mgHikma Farmaceutica (Portugal) S.A.18 Oct 2026not givenNot stated
ESBENDAMUSTINA HIKMA 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 25 mgHikma Farmaceutica (Portugal) S.A.26 Oct 202616 Dec 2026Not stated
BEBendamustine Accord 25 mg/ml inf. sol. (conc.) i.v. vial 5 x 4 mlAccord Healthcare3 Sep 202631 Dec 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Cyclophosphamide Ifosfamide Melphalan Trofosfamide